Nathan Connell/LinkedIn
Sep 29, 2025, 04:51
Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
Vasculearn Network shared on LinkedIn:
”A major step forward for people living with hemophilia, and our very own Nathan Connell, MD, MPH, FACP, VLN Chair of Clinician Education, was one of the lead physicians behind this groundbreaking research.
A new gene therapy could reduce — or even eliminate — the need for regular infusions, giving patients more freedom in their daily lives.
This new approach delivers a functional gene to the liver, helping patients produce clotting factor IX—a protein that plays a critical role in the clotting process.
Watch the full CBS News segment here.”
Stay updated with Hemostasis Today.
-
Jan 11, 2026, 06:18Filippo Cademartiri on Why Vascular Health Is Cognitive Health
-
Jan 11, 2026, 06:01Maira Dastgir N on Cannabis-Induced Ischemic Stroke
-
Jan 11, 2026, 05:51Nishant K Mishra on Preventing Post-Stroke Seizures
-
Jan 11, 2026, 05:41Indunil Karunarathna on CSF Xanthochromia in SAH
-
Jan 11, 2026, 05:22Mitchell Elkind on The New York Times Brain Health Challenge: Food Is Brain Medicine!
-
Jan 11, 2026, 03:55Building Better Care for Bleeding Disorders in Zambia․ Chatowa’s Journey
-
Jan 11, 2026, 03:54Unsupervised Machine Learning for Patient Stratification in Cardiovascular Disease
-
Jan 11, 2026, 03:54DAPT De-escalation After PCI․ Where Do We Stand Today?
-
Jan 11, 2026, 03:53Mostafa Faisal Mohammed: Avatrombopag in Aplastic Anemia